Paolo Gargiulo is a full Professor at - Reykjavik University. He studied at TU Wien and finished his PhD in
2009. Paolo interests and expertise are mostly in: Medical Image processing, Neuroengineering, 3-D printing
and Medical technologies. He developed at Landspitali a 3D-Printing service to support surgical planning
with over 200 operation planned with a significant impact on the Icelandic health care system and he currently
cooperate with institutions in Italy and UK to establish similar infrastructures.
Paolo Gargiulo is the director of the Institute of Biomedical and Neural Engineering and medical technology
center at the University Hospital Landspitali/ Reykjavik University. Paolos lab currently include the
following facilities: high density Electroencephalographic system (256-EEG), Postural control platform and
Virtual reality system and 3D printing and additive manufacturing center.
He has published 100 papers in peer reviewed international journals, several chapters in academic books and
presented his work in many international conferences and workshops.
In January 2019 he received an EU grant, with a project entitled: RESTORE User-centred smart
nanobiomaterial-based 3D matrices for chondral repair. The Icelandic team developed the 1stEuropean
Database of patient-specific anatomical models for condyle lesions. In 2022 he received the 2nd EU grant on
cartilage research the poject is called SINPAIN aiming to Develop the Next-Generation Advanced Therapy
for Knee Osteoarthritis. In 2023 Paolo receive the award as best scientist of the year at Reykjavik University
and the grant of excellence from the Icelandic center of research to study postural control response as
signature of neurodenerative conditions. Paolo Gargiulo is the co-founder of start up company called
Heilalabs which aim is to study brain aging and develop new predictive evaluation metrics for
neurodegenerative desease.